2nd Quarter - Report
W STRATEGIES, LLC for BIOGEN
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of Affordable Care Act as it relates to a regulatory pathway for biosimilars. H.R. 1281: Newborn Screening Saves Lives Reauthorization Act of 2013. H.R. 3303: SOFTWARE Act of 2013. Education about the value of innovative new medicines.Legislative efforts to help accelerate the discovery, development and delivery of promising new treatments to patients (21st Century Cures).
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Copyright/Patent/Trademark CPT
S. 1720: Patent Transparency and Improvements Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.